Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
352 participants
OBSERVATIONAL
2016-10-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Trial of Effect of Low-Cost Maintenance Training on Exercise Capacity, Quality of Life and Morbidity
NCT00214513
Reducing Sedentary Time in Patients With Heart Failure
NCT02911493
Evaluation of Exercise Tolerance and Cardiac Output in Patients With Heart Failure After Intervention of Rehabilitation Program
NCT02928783
Effect of an Eccentric Exercise Program on Quality of Life and Function in People With Chronic Heart Failure.
NCT02223624
Exercise Training Program to Improve Clinical Outcomes in Individuals With Congestive Heart Failure
NCT00047437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The advent of wearable activity and/or health monitors in the health and fitness industry segment has the potential to revolutionize the industry. More importantly, these devices allow new variables to be collected to provide an impact on patients' care and outcome such as steps taken per day.
The intention of the ambulation study is to prevent hospital acquired deconditioning; which in turn would not only decrease the length of stay, but also improve the discharge disposition and place them at home rather than hospice, an extended care facility or rehab. Not only is the intent of the study to decrease the length of stay and also improve the patient's disposition, but also improve their quality of life. In addition, the study will test the effectiveness of the addition of a mobility aide to assist with patients walking on the nursing units.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group - Usual Care
At the start of the study, subjects will be enrolled in usual care when admitted to the heart failure unit following standard protocols.
No interventions assigned to this group
Intervention Group - Aggressive Ambulation
After a washout period and transition to a new aggressive ambulation protocol, subjects will be enrolled to usual care + aggressive planned ambulation with a trained mobility aide.
Aggressive planned ambulation with a mobility aide
A trained mobility aide will provide aggressive ambulation at least 3X per day for all patients on the heart failure unit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aggressive planned ambulation with a mobility aide
A trained mobility aide will provide aggressive ambulation at least 3X per day for all patients on the heart failure unit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The heart group as attending or consultant
* Patient on 5 West at the time of admission
* Admission diagnosis of heart failure
* Age ≥ 18
* Initial assessment completed within 10 hours of admission by a registered nurse
Exclusion Criteria
* Altered weight bearing or unable to complete initial 2 minute walk test
* Unwilling or unable to participate or consent
* Acute delirium or dementia by history
* Hospice or actively dying
* Ventricular assist device or listed for heart transplantation
* Inotrope dependence
* Active ischemia
* Heart rate (HR) \<50 or \>130 at rest
* Blood pressure (BP) \<80 or \>180 at rest
* Pulse oximetry \<88% at rest
* Patient is in isolation for multi-drug resistant organism such as MRSA or C-diff
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lancaster General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Justin Roberts, DO
Role: PRINCIPAL_INVESTIGATOR
Lancaster General Hospital
Lisa Rathman, CRNP
Role: PRINCIPAL_INVESTIGATOR
Lancaster General Hospital
Dana Irwin, BSN, RN
Role: PRINCIPAL_INVESTIGATOR
Lancaster General Hospital
Michael Killinger, MSN, RN
Role: PRINCIPAL_INVESTIGATOR
Lancaster General Hospital
Nathaniel Baker, DPT
Role: PRINCIPAL_INVESTIGATOR
Lancaster General Hospital
Michael Horst, PhD
Role: PRINCIPAL_INVESTIGATOR
Lancaster General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lancaster General Hospital
Lancaster, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHF Inpatient Ambulation Trial
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.